Osteoporosis in men

Research output: Contribution to journalArticle

232 Citations (Scopus)

Abstract

With the aging of the population, there is a growing recognition that osteoporosis and fractures in men are a significant public health problem, and both hip and vertebral fractures are associated with increased morbidity and mortality in men. Osteoporosis in men is a heterogeneous clinical entity: whereas most men experience bone loss with aging, some men develop osteoporosis at a relatively young age, often for unexplained reasons (idiopathic osteoporosis). Declining sex steroid levels and other hormonal changes likely contribute to age-related bone loss, as do impairments in osteoblast number and/or activity. Secondary causes of osteoporosis also play a significant role in pathogenesis. Although there is ongoing controversy regarding whether osteoporosis inmenshould be diagnosed based on female- or male-specific reference ranges (because some evidence indicates that the risk of fracture is similar in women and men for a given level of bone mineral density), a diagnosis of osteoporosis in men is generally made based on male-specific reference ranges. Treatment consists both of nonpharmacological (lifestyle factors, calcium and vitamin D supplementation) and pharmacological (most commonly bisphosphonates or PTH) approaches, with efficacy similar to that seen in women. Increasing awareness of osteoporosis in men among physicians and the lay public is critical for the prevention of fractures in our aging male population.

Original languageEnglish (US)
Pages (from-to)441-464
Number of pages24
JournalEndocrine Reviews
Volume29
Issue number4
DOIs
StatePublished - Jun 2008

Fingerprint

Osteoporosis
Reference Values
Hip Fractures
Diphosphonates
Osteoblasts
Vitamin D
Bone Density
Population
Life Style
Public Health
Steroids
Pharmacology
Calcium
Morbidity
Physicians
Bone and Bones
Mortality

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Osteoporosis in men. / Khosla, Sundeep; Amin, Shreyasee; Orwoll, Eric.

In: Endocrine Reviews, Vol. 29, No. 4, 06.2008, p. 441-464.

Research output: Contribution to journalArticle

Khosla, Sundeep ; Amin, Shreyasee ; Orwoll, Eric. / Osteoporosis in men. In: Endocrine Reviews. 2008 ; Vol. 29, No. 4. pp. 441-464.
@article{ed2d2846b9024350943a1f9e01f1a2a4,
title = "Osteoporosis in men",
abstract = "With the aging of the population, there is a growing recognition that osteoporosis and fractures in men are a significant public health problem, and both hip and vertebral fractures are associated with increased morbidity and mortality in men. Osteoporosis in men is a heterogeneous clinical entity: whereas most men experience bone loss with aging, some men develop osteoporosis at a relatively young age, often for unexplained reasons (idiopathic osteoporosis). Declining sex steroid levels and other hormonal changes likely contribute to age-related bone loss, as do impairments in osteoblast number and/or activity. Secondary causes of osteoporosis also play a significant role in pathogenesis. Although there is ongoing controversy regarding whether osteoporosis inmenshould be diagnosed based on female- or male-specific reference ranges (because some evidence indicates that the risk of fracture is similar in women and men for a given level of bone mineral density), a diagnosis of osteoporosis in men is generally made based on male-specific reference ranges. Treatment consists both of nonpharmacological (lifestyle factors, calcium and vitamin D supplementation) and pharmacological (most commonly bisphosphonates or PTH) approaches, with efficacy similar to that seen in women. Increasing awareness of osteoporosis in men among physicians and the lay public is critical for the prevention of fractures in our aging male population.",
author = "Sundeep Khosla and Shreyasee Amin and Eric Orwoll",
year = "2008",
month = "6",
doi = "10.1210/er.2008-0002",
language = "English (US)",
volume = "29",
pages = "441--464",
journal = "Endocrine Reviews",
issn = "0163-769X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Osteoporosis in men

AU - Khosla, Sundeep

AU - Amin, Shreyasee

AU - Orwoll, Eric

PY - 2008/6

Y1 - 2008/6

N2 - With the aging of the population, there is a growing recognition that osteoporosis and fractures in men are a significant public health problem, and both hip and vertebral fractures are associated with increased morbidity and mortality in men. Osteoporosis in men is a heterogeneous clinical entity: whereas most men experience bone loss with aging, some men develop osteoporosis at a relatively young age, often for unexplained reasons (idiopathic osteoporosis). Declining sex steroid levels and other hormonal changes likely contribute to age-related bone loss, as do impairments in osteoblast number and/or activity. Secondary causes of osteoporosis also play a significant role in pathogenesis. Although there is ongoing controversy regarding whether osteoporosis inmenshould be diagnosed based on female- or male-specific reference ranges (because some evidence indicates that the risk of fracture is similar in women and men for a given level of bone mineral density), a diagnosis of osteoporosis in men is generally made based on male-specific reference ranges. Treatment consists both of nonpharmacological (lifestyle factors, calcium and vitamin D supplementation) and pharmacological (most commonly bisphosphonates or PTH) approaches, with efficacy similar to that seen in women. Increasing awareness of osteoporosis in men among physicians and the lay public is critical for the prevention of fractures in our aging male population.

AB - With the aging of the population, there is a growing recognition that osteoporosis and fractures in men are a significant public health problem, and both hip and vertebral fractures are associated with increased morbidity and mortality in men. Osteoporosis in men is a heterogeneous clinical entity: whereas most men experience bone loss with aging, some men develop osteoporosis at a relatively young age, often for unexplained reasons (idiopathic osteoporosis). Declining sex steroid levels and other hormonal changes likely contribute to age-related bone loss, as do impairments in osteoblast number and/or activity. Secondary causes of osteoporosis also play a significant role in pathogenesis. Although there is ongoing controversy regarding whether osteoporosis inmenshould be diagnosed based on female- or male-specific reference ranges (because some evidence indicates that the risk of fracture is similar in women and men for a given level of bone mineral density), a diagnosis of osteoporosis in men is generally made based on male-specific reference ranges. Treatment consists both of nonpharmacological (lifestyle factors, calcium and vitamin D supplementation) and pharmacological (most commonly bisphosphonates or PTH) approaches, with efficacy similar to that seen in women. Increasing awareness of osteoporosis in men among physicians and the lay public is critical for the prevention of fractures in our aging male population.

UR - http://www.scopus.com/inward/record.url?scp=45149090681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45149090681&partnerID=8YFLogxK

U2 - 10.1210/er.2008-0002

DO - 10.1210/er.2008-0002

M3 - Article

C2 - 18451258

AN - SCOPUS:45149090681

VL - 29

SP - 441

EP - 464

JO - Endocrine Reviews

JF - Endocrine Reviews

SN - 0163-769X

IS - 4

ER -